Variant report
Variant | nsv511345 |
---|---|
Chromosome Location | chr6:69135009-69142008 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:73158464..73161460-chr6:69141039..69142539,2 | K562 | blood: | |
2 | chr17:41400752..41402306-chr6:69141039..69142539,2 | MCF-7 | breast: | |
3 | chr6:69131492..69134265-chr6:69138928..69141362,2 | MCF-7 | breast: | |
4 | chr22:20918726..20919648-chr6:69136151..69136812,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000223247 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs76251388 | chr6:69137612-69137613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534795844 | chr6:69137632-69137633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs17576854 | chr6:69137665-69137666 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs550427540 | chr6:69137762-69137763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs570435386 | chr6:69137783-69137784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs34347075 | chr6:69137787-69137788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142458402 | chr6:69137809-69137810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546379956 | chr6:69137884-69137885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs75073028 | chr6:69137917-69137918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190818617 | chr6:69137953-69137954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs561882633 | chr6:69137965-69137966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs144778576 | chr6:69138029-69138030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs543991565 | chr6:69138047-69138048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs151303351 | chr6:69138052-69138053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183004358 | chr6:69138078-69138079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs3011912 | chr6:69138091-69138092 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs186539484 | chr6:69138172-69138173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs140573897 | chr6:69138188-69138189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs150482161 | chr6:69138215-69138216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573414030 | chr6:69138220-69138221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541546374 | chr6:69138258-69138259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138343660 | chr6:69138263-69138264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191895791 | chr6:69138275-69138276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs377029261 | chr6:69138309-69138310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs62415528 | chr6:69138335-69138336 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs546556111 | chr6:69138351-69138352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114141658 | chr6:69138363-69138364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34203765 | chr6:69138383-69138384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs184289337 | chr6:69139822-69139823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs72893507 | chr6:69139868-69139869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573586378 | chr6:69139896-69139897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188538913 | chr6:69139926-69139927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs193111505 | chr6:69139975-69139976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs576278069 | chr6:69139978-69139979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576620174 | chr6:69139991-69139992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545228662 | chr6:69140062-69140063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs185519043 | chr6:69140084-69140085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533456363 | chr6:69140087-69140088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543816810 | chr6:69140111-69140112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs375754636 | chr6:69140114-69140115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs116806267 | chr6:69140133-69140134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141271943 | chr6:69140160-69140161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189175605 | chr6:69140252-69140253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs180865515 | chr6:69140271-69140272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs376040207 | chr6:69140274-69140275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs117273989 | chr6:69140286-69140287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs184313102 | chr6:69140355-69140356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs551547932 | chr6:69140390-69140391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs547945583 | chr6:69140417-69140418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs79527493 | chr6:69140464-69140465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:69137600-69138400 | Enhancers | NH-A | brain |
2 | chr6:69139800-69142400 | Weak transcription | Stomach Mucosa | stomach |